When will the FDA reclassify BPC 157 to Category 1 Octagon AI FDA Announces Change in Status of 12 Peptides SSRP Institute Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma FDA to Convene Pharmacy Compounding Advisory Committee in July The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York